David H Abramson Selected Research

David H Abramson Research Topics

Disease

140	Retinoblastoma (Glioblastoma, Retinal) 02/2024 - 01/2002
75	Neoplasms (Cancer) 12/2023 - 06/2002
16	Uveal melanoma 06/2024 - 04/2011
13	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2005
9	Melanoma (Melanoma, Malignant) 06/2022 - 06/2003
7	Retinal Detachment (Retinal Detachments) 01/2019 - 08/2008
6	Disease Progression 05/2020 - 01/2007
5	Toxic Optic Neuropathy 01/2021 - 01/2013
4	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 01/2007
4	Second Primary Neoplasms (Neoplasms, Second) 01/2016 - 06/2002
3	Edema (Dropsy) 08/2023 - 04/2009
3	Nevus (Nevi) 01/2022 - 01/2015
3	Sepsis (Septicemia) 01/2021 - 03/2010
2	Uveitis 04/2024 - 07/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 12/2020
2	Retinal Vein Occlusion 09/2022 - 05/2020
2	Macular Edema 09/2022 - 07/2014
2	Central Serous Chorioretinopathy 12/2021 - 12/2017
2	Inflammation (Inflammations) 09/2021 - 12/2020
2	Retinal Telangiectasis 03/2021 - 01/2010
2	Fever (Fevers) 01/2021 - 08/2010
2	Adenocarcinoma 09/2020 - 10/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2019 - 03/2008
2	Necrosis 12/2015 - 01/2002
2	Ischemia 07/2014 - 08/2008
2	Neutropenia 01/2014 - 08/2010
2	Neuroblastoma 07/2013 - 03/2004
2	Hemorrhage 01/2012 - 08/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2007 - 03/2004
1	Multiple Myeloma 11/2023
1	Retinal Neoplasms 03/2023
1	Circulating Neoplastic Cells 01/2023
1	Hyperplasia 01/2023
1	Residual Neoplasm 01/2023
1	Rhabdomyosarcoma 10/2022
1	Endometrial Neoplasms (Endometrial Cancer) 09/2022

Drug/Important Bio-Agent (IBA)

32	Melphalan (Alkeran)FDA LinkGeneric 12/2022 - 08/2008
30	Retinaldehyde (Retinal)IBA 01/2022 - 03/2005
23	Topotecan (Hycamtin)FDA LinkGeneric 03/2023 - 08/2007
17	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 10/2003
8	Circulating Tumor DNAIBA 06/2024 - 03/2021
8	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2004
7	DNA (Deoxyribonucleic Acid)IBA 06/2024 - 10/2004
5	Cell-Free Nucleic AcidsIBA 06/2024 - 01/2020
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2023 - 03/2017
5	SteroidsIBA 01/2023 - 07/2014
4	Bevacizumab (Avastin)FDA Link 06/2022 - 01/2010
3	Immune Checkpoint InhibitorsIBA 06/2024 - 11/2020
3	IpilimumabIBA 06/2024 - 07/2014
3	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 03/2004
3	Mitogen-Activated Protein KinasesIBA 09/2022 - 06/2014
3	pembrolizumabIBA 09/2022 - 06/2020
3	Retinoblastoma ProteinIBA 10/2014 - 12/2006
2	NivolumabIBA 06/2024 - 09/2020
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2023 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 10/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 07/2017
2	AZD 6244IBA 03/2017 - 06/2014
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2016 - 07/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2015 - 02/2013
2	Therapeutic UsesIBA 01/2013 - 07/2009
2	Cardiac GlycosidesIBA 09/2011 - 07/2009
2	Ouabain (G Strophanthin)IBA 09/2011 - 07/2009
2	A-factor (Streptomyces)IBA 07/2010 - 07/2007
1	Phosphotransferases (Kinase)IBA 04/2024
1	Immunoglobulin A (IgA)IBA 11/2023
1	MitogensIBA 08/2023
1	Monoclonal AntibodiesIBA 01/2023
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2023
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2022
1	lenvatinibIBA 09/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2022
1	Immunoconjugates (Immunoconjugate)IBA 06/2022

Therapy/Procedure

86	Drug Therapy (Chemotherapy) 02/2024 - 01/2002
42	Therapeutics 12/2023 - 09/2004
22	Radiotherapy 01/2023 - 01/2002
13	Aftercare (After-Treatment) 02/2024 - 05/2004
12	Brachytherapy 12/2022 - 06/2003
11	Intravitreal Injections 01/2021 - 01/2014
10	Injections 01/2021 - 10/2015
7	Lasers (Laser) 01/2023 - 05/2004
6	Induced Hyperthermia (Thermotherapy) 01/2015 - 06/2003
5	Anesthesia 01/2021 - 01/2014
5	Salvage Therapy 01/2018 - 05/2004
4	Immunotherapy 10/2023 - 09/2021
4	Intraocular Injections 01/2017 - 08/2007
3	Adjuvant Chemotherapy 01/2019 - 07/2007
3	Cryotherapy (Therapy, Cold) 10/2013 - 05/2004
2	Intra-Arterial Infusions 03/2023 - 07/2009
2	Eye Enucleation (Enucleation, Eye) 01/2023 - 01/2020
2	Conservative Treatment 01/2022 - 09/2021
2	Light Coagulation 01/2019 - 01/2010
2	Vitrectomy 01/2019 - 09/2013
2	Orbital Implants 07/2015 - 10/2013
2	Intravenous Infusions 01/2015 - 08/2007
2	Photochemotherapy (Photodynamic Therapy) 08/2004 - 06/2003
1	Stem Cell Transplantation 11/2023
1	Combined Modality Therapy 01/2023
1	Induction Chemotherapy 01/2023
1	Perioperative Period 12/2022